VIDEO: Roflumilast foam well tolerated, effective in patients with scalp psoriasis

In this video from AAD VMX 2021, Kim A. Papp, MD, discusses a recent study investigating safety and efficacy of once-daily roflumilast foam 0.3% in patients with scalp and body psoriasis.